COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry

Meryl Waldman1, Maria Jose Soler2,3, Clara García-Carro2,3

  • 1Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Kidney360
|April 4, 2022
PubMed

Insights

COVID-19 infection did not increase mortality or acute kidney injury (AKI) in glomerulonephritis (GN) patients. However, GN patients face higher risks of impaired kidney function recovery after COVID-19-associated AKI.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on individuals with glomerulonephritis (GN) remains incompletely understood.
  • The International Registry of COVID-19 infection in GN was established to investigate these effects.

Purpose of the Study:

  • To evaluate the acute and long-term effects of COVID-19 on patients with GN.
  • To compare outcomes between GN patients and non-GN controls following SARS-CoV-2 infection.

Main Methods:

  • Serial data on kidney-related and unrelated outcomes were collected from 125 GN patients and 83 non-GN controls with COVID-19.
  • Follow-up duration was a median of 6.4 months post-diagnosis.
  • Logistic regression and linear mixed models were used for outcome and eGFR analyses, adjusted for confounders.

Main Results:

  • No significant differences in mortality or acute kidney injury (AKI) were observed between GN patients and controls after adjusting for pre-COVID-19 eGFR and other factors.
  • Pre-COVID-19 eGFR was the primary predictor of AKI (aOR per 1 SD decrease = 3.04, P<0.001).
  • GN patients with COVID-19-associated AKI showed significantly lower eGFR recovery at 6 months compared to controls (aOR=0.41). Factors like shorter GN duration, higher proteinuria, and specific diagnoses (FSGS, MCD) were linked to poorer eGFR recovery.

Conclusions:

  • Baseline eGFR is the key risk factor for AKI in COVID-19, irrespective of GN diagnosis.
  • Glomerulonephritis patients exhibit a heightened risk of impaired eGFR recovery post-COVID-19-associated AKI.
  • Close monitoring of GN patients, particularly those with high proteinuria or diagnoses of FSGS/MCD, is crucial during and after acute COVID-19 illness.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
69
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
131
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
128
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
106
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
90
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
130